Braemar Hotels & Resorts Inc. (BHR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q3 '21: 348.9M Q4 '21: 427.5M Q1 '22: 505.6M Q2 '22: 583.4M Q3 '22: 628.4M Q4 '22: 669.6M Q1 '23: 723M Q2 '23: 734.8M Q3 '23: 733.4M Q4 '23: 739.3M Q1 '24: 743.1M Q2 '24: 744M Q3 '24: 732.6M Q4 '24: 728.4M Q1 '25: 725.1M Q2 '25: 716.6M Q3 '25: 711.8M Q4 '25: 704M Q1 '26: 697.2M Q2 '26: 689.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 60M 120M 180M Q3 '21: 32.9M Q4 '21: 66.8M Q1 '22: 102.2M Q2 '22: 131.2M Q3 '22: 139.2M Q4 '22: 146M Q1 '23: 157.8M Q2 '23: 155M Q3 '23: 146.8M Q4 '23: 144.9M Q1 '24: 145.9M Q2 '24: 141.5M Q3 '24: 130.5M Q4 '24: 127.9M Q1 '25: 127M Q2 '25: 123.2M Q3 '25: 122.3M Q4 '25: 119.3M Q1 '26: 119.1M Q2 '26: 120.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-100M -50M 0 50M 100M 150M Q4 '20: -79.9M Q1 '21: -80.3M Q2 '21: -43.3M Q3 '21: -27.9M Q4 '21: 1.4M Q1 '22: 31.6M Q2 '22: 61.2M Q3 '22: 63.2M Q4 '22: 68.4M Q1 '23: 79.7M Q2 '23: 70.4M Q3 '23: 67.9M Q4 '23: 61.7M Q1 '24: 66.3M Q2 '24: 61.1M Q3 '24: 130.8M Q4 '24: 128.8M Q1 '25: 123M Q2 '25: 128.7M Q3 '25: 88.2M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Net Income TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: -50.6M Q4 '21: -26.7M Q1 '22: -3.3M Q2 '22: 20.3M Q3 '22: 19.2M Q4 '22: 17.8M Q1 '23: 19.1M Q2 '23: 2.9M Q3 '23: -11.1M Q4 '23: -27M Q1 '24: -27.1M Q2 '24: -36.8M Q3 '24: -2.2M Q4 '24: -14.2M Q1 '25: -19.1M Q2 '25: -13M Q3 '25: -19.9M Q4 '25: -22.3M Q1 '26: -15.6M Q2 '26: -3.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 200M 400M 600M Q3 '21: 243.2M Q4 '21: 287M Q1 '22: 329.6M Q2 '22: 377M Q3 '22: 412.6M Q4 '22: 445.5M Q1 '23: 483M Q2 '23: 494.6M Q3 '23: 498.4M Q4 '23: 501.2M Q1 '24: 501.1M Q2 '24: 504.2M Q3 '24: 501.5M Q4 '24: 501.7M Q1 '25: 501.4M Q2 '25: 498.1M Q3 '25: 496M Q4 '25: 492.2M Q1 '26: 486.3M Q2 '26: 478.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 50M 100M 150M Q3 '21: 40.5M Q4 '21: 64M Q1 '22: 80.8M Q2 '22: 112.3M Q3 '22: 112.8M Q4 '22: 109.5M Q1 '23: 123M Q2 '23: 91.6M Q3 '23: 78.5M Q4 '23: 84.7M Q1 '24: 78.4M Q2 '24: 82.9M Q3 '24: 71.9M Q4 '24: 66.8M Q1 '25: 45.9M Q2 '25: 44.9M Q3 '25: 39.1M Q4 '25: 40.8M Q1 '26: 47.6M Q2 '26: 45.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-270M -180M -90M 0 90M 180M 270M Q4 '21: 46.3M Q1 '22: -23.8M Q2 '22: 10.9M Q3 '22: 17.9M Q4 '22: -245M Q1 '23: -144.5M Q2 '23: -176M Q3 '23: -189.1M Q4 '23: 84.7M Q4 '21 Q2 '22 Q4 '22 Q2 '23 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 100M 200M 300M Q1 '20: 32.5M Q2 '20: 32.9M Q3 '20: 33.9M Q1 '21: 39.6M Q2 '21: 47.8M Q3 '21: 59.2M Q1 '22: 89.9M Q2 '22: 107.7M Q3 '22: 71M Q1 '23: 72.5M Q2 '23: 65.8M Q3 '23: 65.8M Q1 '24: 268.5M Q2 '24: 66.5M Q3 '24: 66.5M Q1 '25: 66.7M Q2 '25: 67.3M Q3 '25: 68.2M Q1 '26: 100.3M Q2 '26: 68.7M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q2 '15: 0.31 Q3 '15: -0.11 Q4 '15: -0.29 Q2 '18: 0.92 Q3 '18: 0.89 Q4 '18: -0.20 Q1 '20: -0.71 Q2 '20: -2.02 Q3 '20: -2.28 Q4 '20: -3.40 Q1 '21: -3.20 Q2 '21: -1.99 Q3 '21: -1.51 Q4 '21: -0.78 Q1 '22: -0.35 Q2 '22: 0.09 Q3 '22: -0.00 Q4 '22: -0.15 Q2 '24: -1.28 Q1 '26: -0.96 Q3 '15 Q3 '18 Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.